Kawasaki disease: aetiopathogenesis and therapeutic utility of intravenous immunoglobulin

Caroline Galeotti1, Jagedeesh Bayry, Isabelle Kone-Paut

  • 1INSERM U 872, Centre de Recherche des Cordeliers, Paris, F-75006, France.

Autoimmunity Reviews
|December 17, 2009
PubMed

Insights

Kawasaki disease, an acute febrile vasculitis in children, can cause coronary artery issues. Intravenous immunoglobulin (IVIG) effectively prevents these abnormalities by modulating immune responses.

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Vascular Biology

Background:

  • Kawasaki disease (KD) is a critical pediatric vasculitis.
  • It affects children, leading to coronary artery abnormalities in up to 30% of untreated cases.
  • The exact cause is unknown but involves an infectious trigger in genetically susceptible individuals.

Purpose of the Study:

  • To explore the mechanisms behind Kawasaki disease.
  • To understand the role of endothelial cell injury and immune responses.
  • To investigate how intravenous immunoglobulin (IVIG) prevents coronary artery abnormalities.

Main Methods:

  • Review of existing literature on Kawasaki disease pathogenesis.
  • Analysis of immune system components involved in KD.
  • Examination of IVIG's therapeutic effects on immune cells.

Main Results:

  • KD involves endothelial cell injury, potentially from abnormal cytokine production and cytotoxic antibodies.
  • Intravenous immunoglobulin (IVIG) is a proven treatment for preventing coronary artery abnormalities.
  • IVIG exerts anti-inflammatory effects by altering cytokine balance and modulating immune cell function.

Conclusions:

  • Kawasaki disease is an immune-mediated vasculitis with significant cardiovascular risks.
  • IVIG is crucial for managing KD and preventing long-term complications.
  • Further research into KD's pathogenesis can refine treatment strategies.

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...